Pharmacokinetics, optimal dosages and withdrawal time of amoxicillin in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C

Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages...

Full description

Saved in:
Bibliographic Details
Published inThe Veterinary quarterly Vol. 44; no. 1; pp. 1 - 9
Main Authors Rairat, Tirawat, Lu, Yi-Ping, Ho, Wan-Cih, Ke, Hual-Jhong, Chou, Chi-Chung
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.12.2024
Taylor & Francis Ltd
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture.
AbstractList Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia ( ) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture.
Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture.
Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture.Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture.
Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to explore the PK characteristics of AMX in Nile tilapia ( Oreochromis niloticus ) reared at 25 and 30 °C as well as to determine optimal dosages and drug withdrawal time (WDT). In the PK investigation, the fish received a single dose of 40 mg/kg AMX via oral gavage, and the optimal dosage was determined by the pharmacokinetic-pharmacodynamic approach. In the tissue residue study, the fish were orally gavaged with 40 mg/kg/day AMX once daily for 5 days and the WDT was established by the linear regression analysis. The results revealed the temperature-dependent drug elimination; the clearance relative to bioavailability (CL/F) and elimination half-life at 30 °C (0.180 L/kg/h and 6.06 h, respectively) were about twice those at 25 °C (0.090 L/kg/h and 10.49 h, respectively). The optimal dosages at the minimum inhibitory concentration (MIC) of 2 μg/mL were 10.97 (25 °C) and 41.03 (30 °C) mg/kg/day, respectively. Finally, following the multiple oral administration, the muscle/skin residue of AMX on day 1 after the last dosing at 25 and 30 °C were 548 and 264 ng/g, respectively. The average tissue residues were depleted below the maximum residue limits (MRL) of 50 μg/kg on day 5 (25 °C) and 3 (30 °C), respectively, and the WDT were 6 and 4 days when rearing at 25 and 30 °C, respectively. This knowledge serves as a practical guideline for responsible use of AMX in treating bacterial diseases in Nile tilapia aquaculture.
Author Rairat, Tirawat
Chou, Chi-Chung
Ke, Hual-Jhong
Ho, Wan-Cih
Lu, Yi-Ping
Author_xml – sequence: 1
  givenname: Tirawat
  surname: Rairat
  fullname: Rairat, Tirawat
  organization: Department of Fishery Biology, Kasetsart University
– sequence: 2
  givenname: Yi-Ping
  surname: Lu
  fullname: Lu, Yi-Ping
  organization: Biology Division, Veterinary Research Institute, Ministry of Agriculture
– sequence: 3
  givenname: Wan-Cih
  surname: Ho
  fullname: Ho, Wan-Cih
  organization: Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University
– sequence: 4
  givenname: Hual-Jhong
  surname: Ke
  fullname: Ke, Hual-Jhong
  organization: Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University
– sequence: 5
  givenname: Chi-Chung
  surname: Chou
  fullname: Chou, Chi-Chung
  organization: Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39192627$$D View this record in MEDLINE/PubMed
BookMark eNp9kstuEzEUhi1URC_wCCBLbIpEgq8z4xWgiEulirKAtXXG40kcHDvYE0J3rJB4G56BR-FJ8DRpRVkgWbLk85_Pv4__Y3QQYrAIPaRkSklDnhFaSUbrasoIE1PGVSVrfgcd0aaWE6kEPUBHo2Yyig7Rcc5LQgSRorqHDrmiilWsPkLf3y8grcDETy7YwZn8FMf14FbgcRczzG3GEDq8dcOiS7Atx6VocewxrOJXZ5z3LuCy3jlvS83D2gE-vUg2mkWKK5dxcD4W8iY_wclCsh2GATN5xeXk97cfv37O7qO7PfhsH-z3E_Tx9asPs7eT84s3Z7OX5xMjKR0mtK-pssoKxdpWyFYxzgxTDREtFcAU6yUDVgEnxAAVQjDaNX1DJa-s5L3iJ-hsx-0iLPU6lYemSx3B6auDmOYaUjHrraaiTKnMSKpyX22gqZqWt0Qo2UoBRBbW8x1rvWlXtjM2DAn8LejtSnALPY9fNKW8IhWnhXC6J6T4eWPzoMu8jPUego2brDlRdSMZE6P08T_SZdykUGalORWkappajJYe_W3pxsv1fxeB3AlMijkn299IKNFjrvR1rvSYK73PVel7setzoY8lL9uYfKcHuPQx9QmCcaOP_yL-AG9y00k
Cites_doi 10.1016/j.aquaculture.2019.02.042
10.1111/j.1095-8649.1987.tb05276.x
10.1002/9781118675014.ch39
10.1111/j.1365-2885.2010.01231.x
10.4315/0362-028x-73.9.1664
10.1016/j.aquaculture.2019.734542
10.3390/pharmaceutics14040712
10.1111/are.13555
10.1046/j.1365-2656.1999.00337.x
10.1002/9781118675014.ch16
10.1046/j.1365-2109.2002.00783.x
10.1016/j.aqrep.2019.100184
10.1002/9781118675014.ch8
10.1111/jvp.12321
10.3390/ani13162568
10.1111/jfd.13137
10.1016/j.aquaculture.2019.734900
10.1016/j.aquaculture.2022.738719
10.1016/S0044-8486(02)00367-8
10.1577/H03-016
10.1016/j.cmpb.2010.01.007
10.1021/acs.est.2c09576
10.1021/es062437y
10.3390/pharmaceutics15041153
10.1111/jfd.13480
10.1111/jfd.13040
10.1016/0044-8486(92)90285-S
10.3109/00498254.2015.1089453
10.1111/j.1461-0248.2009.01415.x
10.1577/H04-033.1
10.1111/jvp.12773
10.1111/are.12764
10.1111/j.1365-2885.2004.00602.x
10.1016/0044-8486(90)90101-R
10.1016/S0044-8486(03)00452-6
10.1016/j.aquaculture.2018.12.081
10.1080/02772240903109092
10.1007/s10499-006-9047-0
10.1111/jwas.12131
10.1080/19440049.2022.2155710
10.1142/S1682648515500055
10.1111/jfd.13719
ContentType Journal Article
Copyright 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024
2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s)
Copyright_xml – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024
– notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s)
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1080/01652176.2024.2396573
DatabaseName Taylor & Francis Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
ProQuest Central Student
ProQuest Research Library
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Veterinary Medicine
DocumentTitleAlternate T. Rairat et al
EISSN 1875-5941
EndPage 9
ExternalDocumentID oai_doaj_org_article_14391627599e47ca868b3b0495b54a05
PMC11360631
39192627
10_1080_01652176_2024_2396573
2396573
Genre Research Article
Journal Article
GrantInformation_xml – fundername: Animal and Plant Health Inspection Agency, Ministry of Agriculture, Executive Yuan, Taiwan
  grantid: 110AS-6.4.1-BQ-B1
GroupedDBID ---
.7F
.QJ
0YH
123
4.4
53G
8G5
AAENE
AAHBH
ABCCY
ABFIM
ABUWG
ACGFS
ADBBV
ADCVX
AENEX
AFKRA
AGMYJ
ALMA_UNASSIGNED_HOLDINGS
AVBZW
AZQEC
BCNDV
BENPR
CCPQU
CE4
DGEBU
DWQXO
EBS
ECGQY
EYRJQ
E~A
E~B
F5P
GNUQQ
GROUPED_DOAJ
GTTXZ
GUQSH
H13
HF~
HYE
HZ~
H~P
IPNFZ
J.P
M2O
M4Z
NA5
O9-
OK1
PIMPY
PROAC
RIG
RPM
S-T
TDBHL
TEI
TFL
TFW
UT5
UU3
~KM
~S~
AAYXX
CITATION
NX0
PHGZM
PHGZT
07X
AAOAP
APNXG
AURDB
BFWEY
BPHCQ
C0.
CGR
CUY
CVF
CWRZV
DLOXE
ECM
EIF
EJD
HGUVV
JEPSP
L84
NPM
NUSFT
OWHGL
PCLFJ
PQQKQ
TTHFI
UB7
3V.
7QL
7XB
8FK
C1K
MBDVC
PKEHL
PQEST
PQUKI
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c511t-1f719e9e492bb45b9232c29804b14a292f52a26a300ca144421d8f81536e53f93
IEDL.DBID 0YH
ISSN 0165-2176
1875-5941
IngestDate Wed Aug 27 01:10:42 EDT 2025
Thu Aug 21 18:32:02 EDT 2025
Thu Jul 10 18:54:55 EDT 2025
Mon Jun 30 13:53:14 EDT 2025
Thu Jan 02 22:38:39 EST 2025
Tue Jul 01 03:34:17 EDT 2025
Wed Dec 25 09:04:05 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords aquaculture
withdrawal period
tissue residue
Antimicrobials
penicillins
fish
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-1f719e9e492bb45b9232c29804b14a292f52a26a300ca144421d8f81536e53f93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.tandfonline.com/doi/abs/10.1080/01652176.2024.2396573
PMID 39192627
PQID 3140688745
PQPubID 3933323
PageCount 9
ParticipantIDs informaworld_taylorfrancis_310_1080_01652176_2024_2396573
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11360631
proquest_journals_3140688745
doaj_primary_oai_doaj_org_article_14391627599e47ca868b3b0495b54a05
proquest_miscellaneous_3097852241
crossref_primary_10_1080_01652176_2024_2396573
pubmed_primary_39192627
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-Dec
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-Dec
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: The Hague
PublicationTitle The Veterinary quarterly
PublicationTitleAlternate Vet Q
PublicationYear 2024
Publisher Taylor & Francis
Taylor & Francis Ltd
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
– name: Taylor & Francis Group
References AphA (e_1_3_4_3_1) 2014
Kumphaphat S (e_1_3_4_24_1) 2022
e_1_3_4_9_1
e_1_3_4_42_1
e_1_3_4_7_1
e_1_3_4_40_1
e_1_3_4_5_1
e_1_3_4_23_1
e_1_3_4_46_1
e_1_3_4_21_1
e_1_3_4_44_1
e_1_3_4_27_1
e_1_3_4_25_1
e_1_3_4_48_1
e_1_3_4_29_1
e_1_3_4_53_1
e_1_3_4_30_1
e_1_3_4_51_1
e_1_3_4_13_1
e_1_3_4_34_1
e_1_3_4_55_1
e_1_3_4_11_1
e_1_3_4_32_1
AVMA (e_1_3_4_4_1) 2020
e_1_3_4_38_1
Trevor AJ (e_1_3_4_49_1) 2015
e_1_3_4_36_1
EC (e_1_3_4_15_1) 2023
FAO (e_1_3_4_17_1) 2021
Gilbert DN (e_1_3_4_19_1) 2022
e_1_3_4_2_1
e_1_3_4_8_1
e_1_3_4_20_1
e_1_3_4_41_1
e_1_3_4_6_1
e_1_3_4_45_1
e_1_3_4_22_1
e_1_3_4_43_1
e_1_3_4_26_1
e_1_3_4_47_1
Lin M (e_1_3_4_28_1) 2015; 7
e_1_3_4_31_1
e_1_3_4_52_1
e_1_3_4_50_1
e_1_3_4_12_1
e_1_3_4_35_1
e_1_3_4_10_1
e_1_3_4_33_1
e_1_3_4_54_1
e_1_3_4_16_1
FAO (e_1_3_4_18_1) 2022
e_1_3_4_39_1
e_1_3_4_14_1
e_1_3_4_37_1
e_1_3_4_56_1
References_xml – ident: e_1_3_4_34_1
  doi: 10.1016/j.aquaculture.2019.02.042
– volume-title: The Sanford guide to antimicrobial therapy 2022
  year: 2022
  ident: e_1_3_4_19_1
– ident: e_1_3_4_5_1
  doi: 10.1111/j.1095-8649.1987.tb05276.x
– ident: e_1_3_4_43_1
  doi: 10.1002/9781118675014.ch39
– ident: e_1_3_4_26_1
  doi: 10.1111/j.1365-2885.2010.01231.x
– ident: e_1_3_4_45_1
  doi: 10.4315/0362-028x-73.9.1664
– ident: e_1_3_4_55_1
  doi: 10.1016/j.aquaculture.2019.734542
– ident: e_1_3_4_53_1
  doi: 10.3390/pharmaceutics14040712
– volume-title: The context of tilapia value chain development in Thailand. Bangkok: Food and agriculture organization of the United Nations
  year: 2021
  ident: e_1_3_4_17_1
– ident: e_1_3_4_33_1
  doi: 10.1111/are.13555
– ident: e_1_3_4_9_1
  doi: 10.1046/j.1365-2656.1999.00337.x
– ident: e_1_3_4_14_1
  doi: 10.1002/9781118675014.ch16
– ident: e_1_3_4_44_1
  doi: 10.1046/j.1365-2109.2002.00783.x
– ident: e_1_3_4_21_1
  doi: 10.1016/j.aqrep.2019.100184
– ident: e_1_3_4_35_1
  doi: 10.1002/9781118675014.ch8
– ident: e_1_3_4_51_1
– ident: e_1_3_4_27_1
  doi: 10.1111/jvp.12321
– ident: e_1_3_4_54_1
  doi: 10.3390/ani13162568
– ident: e_1_3_4_31_1
  doi: 10.1111/jfd.13137
– ident: e_1_3_4_42_1
  doi: 10.1016/j.aquaculture.2019.734900
– ident: e_1_3_4_36_1
  doi: 10.1016/j.aquaculture.2022.738719
– ident: e_1_3_4_50_1
  doi: 10.1016/S0044-8486(02)00367-8
– ident: e_1_3_4_12_1
  doi: 10.1577/H03-016
– ident: e_1_3_4_47_1
– volume-title: Commission regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, 02010R0037-20230611
  year: 2023
  ident: e_1_3_4_15_1
– ident: e_1_3_4_56_1
  doi: 10.1016/j.cmpb.2010.01.007
– ident: e_1_3_4_16_1
– ident: e_1_3_4_30_1
  doi: 10.1021/acs.est.2c09576
– ident: e_1_3_4_10_1
– ident: e_1_3_4_8_1
  doi: 10.1021/es062437y
– ident: e_1_3_4_25_1
  doi: 10.3390/pharmaceutics15041153
– ident: e_1_3_4_37_1
  doi: 10.1111/jfd.13480
– ident: e_1_3_4_38_1
  doi: 10.1111/jfd.13040
– ident: e_1_3_4_7_1
  doi: 10.1016/0044-8486(92)90285-S
– ident: e_1_3_4_32_1
  doi: 10.3109/00498254.2015.1089453
– volume-title: AVMA guidelines for the euthanasia of animals: 2020 edition
  year: 2020
  ident: e_1_3_4_4_1
– ident: e_1_3_4_23_1
  doi: 10.1111/j.1461-0248.2009.01415.x
– ident: e_1_3_4_11_1
  doi: 10.1577/H04-033.1
– ident: e_1_3_4_20_1
  doi: 10.1111/jvp.12773
– volume-title: Drug information handbook with international trade names index
  year: 2014
  ident: e_1_3_4_3_1
– ident: e_1_3_4_29_1
  doi: 10.1111/are.12764
– ident: e_1_3_4_48_1
  doi: 10.1111/j.1365-2885.2004.00602.x
– start-page: 396
  volume-title: Proceedings of the 60th Kasetsart University Annual Conference: Agricultural Sciences
  year: 2022
  ident: e_1_3_4_24_1
– volume-title: Katzung & Trevor’s pharmacology: examination & board review
  year: 2015
  ident: e_1_3_4_49_1
– ident: e_1_3_4_6_1
  doi: 10.1016/0044-8486(90)90101-R
– ident: e_1_3_4_13_1
  doi: 10.1016/S0044-8486(03)00452-6
– ident: e_1_3_4_39_1
  doi: 10.1016/j.aquaculture.2018.12.081
– volume-title: The State of World Fisheries and Aquaculture 2022. Rome: Food and Agriculture Organization of the United Nations
  year: 2022
  ident: e_1_3_4_18_1
– ident: e_1_3_4_2_1
  doi: 10.1080/02772240903109092
– volume: 7
  start-page: 126
  issue: 2
  year: 2015
  ident: e_1_3_4_28_1
  article-title: Comparative pharmacokinetics of florfenicol in Japanese eels at different temperature
  publication-title: Anim Husb Feed Sci
– ident: e_1_3_4_46_1
  doi: 10.1007/s10499-006-9047-0
– ident: e_1_3_4_22_1
  doi: 10.1111/jwas.12131
– ident: e_1_3_4_40_1
  doi: 10.1080/19440049.2022.2155710
– ident: e_1_3_4_52_1
  doi: 10.1142/S1682648515500055
– ident: e_1_3_4_41_1
  doi: 10.1111/jfd.13719
SSID ssj0040546
Score 2.3632
Snippet Knowledge of amoxicillin (AMX) pharmacokinetics (PK) and tissue residues in fish, which is necessary for prudent drug use, remains limited. The study aimed to...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Amoxicillin
Amoxicillin - administration & dosage
Amoxicillin - pharmacokinetics
Animals
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - pharmacokinetics
Antimicrobials
Aquaculture
Bacterial diseases
Bioavailability
Cichlids
Dosage
Dose-Response Relationship, Drug
Drug dosages
Drug Residues
Drug withdrawal
Fish
Half-Life
Microbial Sensitivity Tests
Minimum inhibitory concentration
Oral administration
Oreochromis niloticus
penicillins
Pharmacodynamics
Pharmacokinetics
Regression analysis
Residues
Temperature
Temperature dependence
Tilapia
tissue residue
withdrawal period
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtUwELVQV2wQlFegICOxAImUG78SL6GiqpBaWFDUXTSObbWCJihNRZddIfE3fAOfwpcwEydX91ZI3SBlE78Ue8b2sTNzhrHnLmjbaGXyUHjIlfY6BxNC3viIVYx2PtB9x_6B2TtU74_00UqoL7IJS_TAaeBeF6NrqCi1tUGVDVSmctIhrtVOK0jspbjnzYeptAYjCkkuOgXZcBWlmX13iFUb0ygJz4ZCbQtpjS7l2q40kvdfoS79FwC9ake5sjHt3ma3JkTJ36Se3GE3QrvJNj-Tmcvoa8v3p9_nd9mPjxNR9Rd8JX7mV7zDJeMUq_uOLMzOOLSe092s7-E7JlPoed5FDqfdBTZCBN4cnwNcSzCPPOGAv_jQh6457jtUGd6efO2Iz-PsJe-JHtdzGLjQY7ty8efy5-9fO_fY4e67Tzt7-RSIIW8Qjw15EcvCBhx_K5xT2iEoFI2w1UK5QoGwImoBwoBcLBrAE5oSha9ihYupCVpGK--zjbZrw0PGQVQQjYuVKRslobHBB8BTMmDz0UjI2PYsiPpb4tuoi5nGdJJcTZKrJ8ll7C2Ja1mY6LLHBFSielKi-jolyphdFXY9jLclMYU2qeU1H7A1a0Y9zX-qoiiaT6mw6WfLbBQD_Y6BNnTnWIZcaDRBqIw9SIq07AV-LhE5lhmr1lRsrZvrOe3J8cgOTkF6EHcWj_7HwDxmN6mvyX5ni20M_Xl4gihscE_HCfcXp_Mrgg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwELZge-GCoPwFCjISB5BI2fgv9gnRqlWF1KVCFPUW2bFDK2hcslvBkRMSb8Mz8Cg8CTOJs-pWCKRc4j_ZmslkZjzzDSFPXJCmlkLlofA2F9LL3KoQ8to3MEVJ5wP6O_Znau9QvD6SR8nhNk9hlaNM7AW1jzX6yF9wsASURnD2l2efc6wahberqYTGVbIGIljrCVnb2pkdvB1lMWgjQ6pOgbFcRanGHB5E14Y2bAIbkYlNxo2SJV_5O_Ug_pcgTP-miF6Op7zwg9q9Qa4nzZK-GljhJrkS2nWy_h7DXfqcW7qfrtFvke8HCbD6I7wiTvNzGkF0nMJ0HzHSbE5t6yn6aH1nv0AzlqCnsaH2NH6FRRDIm8IzA5kCfZgRZ-nTN12I9XEXgXVoe_IpIq7H_BntECbXU7ugTPbr8unvbz9-_dy-TQ53d95t7-WpIENeg162yIumLEwwQRjmnJAOlENWM6OnwhXCMsMaySxTlk-ntQVLTbDC60aDUFVB8sbwO2TSxjbcI9QybRvlGq3KWnBbm-CDBWvZwvKN4jYjmyMhqrMBd6MqRjjTRLkKKVclymVkC8m1HIyw2X1D7D5U6SsEOwfzjFkpDRyirK1W2nEHRpJ0UtipzIi5SOxq0XtNmqHEScX_s4GNkTOqJAdwysi1GXm87AYy4LWMbUM8hzGYSiNRlcrI3YGRlqeA7SKgY5kRvcJiK8dc7WlPjnuUcCzWA_pncf_f-3pAruEphgidDTJZdOfhIehZC_cofUx_AGqAJiQ
  priority: 102
  providerName: ProQuest
Title Pharmacokinetics, optimal dosages and withdrawal time of amoxicillin in Nile tilapia (Oreochromis niloticus) reared at 25 and 30 °C
URI https://www.tandfonline.com/doi/abs/10.1080/01652176.2024.2396573
https://www.ncbi.nlm.nih.gov/pubmed/39192627
https://www.proquest.com/docview/3140688745
https://www.proquest.com/docview/3097852241
https://pubmed.ncbi.nlm.nih.gov/PMC11360631
https://doaj.org/article/14391627599e47ca868b3b0495b54a05
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELagvXBBUP4CZWUkDiCRkji2Ex9p1WqF1KVCFMEpGid2W0FjlN2qPXJC4m14Bh6FJ2EmP6tuBeKAlEvieGRnxuMZZ-Ybxp5ap0ylpI5dWkMsVa1i0M7FVe2xi1a2dnTesT_T00P5-oMaownnQ1gl-dC-B4rodDUtbrDzMSLuJWXgoCVNAQZCbonMaJVn19k67sQJFTFIPk5HZYzmSJ-rk1IwF_YZk3j-RmZle-pQ_K9gmP7JEr0aUHlph9q7xW4OpiV_1cvCbXbNNRts4z3Fu3RJt3x_-I9-h307GBCrP-EtATW_4AF1xyl2rwOFms05fh1Oh7R1C-f4mGrQ8-A5nIYLJEJI3hyvGSoVbKOUOODP3rQuVMdtQNnhzcnnQMAe8-e8JZzcmsOCC9XRzZJfX7___LFzlx3u7b7bmcZDRYa4QsNsEac-T40zThphrVQWrUNRCVMk0qYShBFeCRAasiSpAF01KdK68AVqVe1U5k12j601oXEPGAdRgNfWFzqvZAaVcbUDdJcByXudQcS2RkaUX3rgjTId8UwHzpXEuXLgXMS2iV3Llwk3u3sQ2qNyWIbo6FCisciVwUnkFRS6sJlFL0lZJSFRETOXmV0uumMT39c4KbN_DGBzlIxyUATURVJZn1wi6SfLZmQD_ZeBxoUzfIdyaRTZUhG73wvSchY4XEJ0zCNWrIjYyjRXW5qT4w4mnKr1oAGaPvyPOT1iN-i2j9_ZZGuL9sw9RitsYSfdOpuw9e3d2cHbSXeW8RuAQiye
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaq9gAXBOUVKGAkkEAiJfEryQEhWlptaXepUIt6C3bs0Aoal-xWhRsnJP4M4jfwU_glzOSx6lYITpVyiV-yNePxjD3zDSEPjJNZIYUKXWx1KKSVoVbOhYUtoYuSxjq87xiO1GBXvNqTe3PkRx8Lg26VvUxsBLX1Bd6RP-VgCagUwdmfH30KMWsUvq72KTRatth0X07AZBs_23gJ9H3I2Prazuog7LIKhAUoF5MwLpM4c5kTGTNGSAMaDitYlkbCxEKzjJWSaaY0j6JCg7khWGzTMgXJoJzkJYIvgchfEFxFbJ4srKyNtt_0sh-0nzY0KEbfsThRfcwQonlDGRaBTcrEMuOZkgmfOQ2bpAFnIFP_pvie9d88dSCuXyaXOk2WvmhZ7wqZc9UiWXyL7jVNjC8dds_2V8m37Q4g-wP8Ii70E-pBVB1Cd-vRs21MdWUp3gnbWp9AMaa8p76k-tB_hkEQOJzCNwIZBnUYgafpo9e188V-7YFVaXXw0SOOyPgxrRGW11I9oUw24_Lo99fvv36uXiO750Kq62S-8pW7SahmqS6VKVOVFILrInPWabDONQxfKq4DstwTIj9qcT7yuIdP7SiXI-XyjnIBWUFyTRsjTHdT4Ov3ebfrwa7CuGaWyAwWkRQ6VanhBowyaaTQkQxIdprY-aS5pSnblCo5_88ElnrOyDu5g136XRKQ-9NqIAM-A-nK-WNog6E7ElW3gNxoGWm6CpguAkgmAUlnWGxmmbM11cF-g0qOyYFA341v_Xte98iFwc5wK9_aGG3eJhdxRa130BKZn9TH7g7oeBNzt9tYlLw77738BwfkYGk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIgLgvJaKGAkDiCRNvEr8REKq-XRpQeK4BTZsU0raFxlU8GRExL_ht_AT-GXMJPHqluBOCDlkjge2ZnxeMaZ-YaQ-9ZLXUmhEp85kwjpZGKU90nlAnRR0jqP5x07czXbEy_eyTGacDGEVaIPHXqgiE5X4-I-cmGMiNvCDBywpDHAgIlNxrWSOT9LzknYe7F6Q_p-NipjMEf6XJ0Mg7mgz5jE8zcyK9tTh-J_CsP0T5bo6YDKEzvU9BK5OJiW9HEvC5fJGV-vk_W3GO_SJd3SneE_-hXybXdArP4ItwjU_IhG0B2H0N1FDDVbUPg6FA9pXWM-w2OsQU9joOYwfgEiiORN4ZqDUoE2TIkz9MHrxsdqv4kgO7Q--BQR2GPxkDaIk-uoaSmTHV2e_vr6_eeP7atkb_rszfYsGSoyJBUYZm2ShTzTXnuhmbVCWrAOWcV0kQqbCcM0C5IZpgxP08qAqyZY5opQgFZVXvKg-TWyVsfa3yDUsMIEZUOh8kpwU2nvvAF32QD5oLiZkM2REeVRD7xRZiOe6cC5EjlXDpybkCfIruXLiJvdPYjNh3JYhuDoYKIxy6WGSeSVKVRhuQUvSVopTConRJ9kdtl2xyahr3FS8n8MYGOUjHJQBNhFYFmfXADpe8tmYAP-lzG1j8fwDubSSLSlJuR6L0jLWcBwEdExn5BiRcRWprnaUh_sdzDhWK0HDNDs5n_M6S45v_t0Wr56Pn95i1zAlj6UZ4Ostc2xvw0GWWvvdEvuNz7ULKw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetics%2C+optimal+dosages+and+withdrawal+time+of+amoxicillin+in+Nile+tilapia+%28+Oreochromis+niloticus+%29+reared+at+25+and+30%E2%80%89%C2%B0C&rft.jtitle=The+Veterinary+quarterly&rft.au=Rairat%2C+Tirawat&rft.au=Lu%2C+Yi-Ping&rft.au=Ho%2C+Wan-Cih&rft.au=Ke%2C+Hual-Jhong&rft.date=2024-12-01&rft.issn=0165-2176&rft.eissn=1875-5941&rft.volume=44&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1080%2F01652176.2024.2396573&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_01652176_2024_2396573
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0165-2176&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0165-2176&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0165-2176&client=summon